These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 1347295)
1. Changes in normal glycosylation mechanisms in autoimmune rheumatic disease. Axford JS; Sumar N; Alavi A; Isenberg DA; Young A; Bodman KB; Roitt IM J Clin Invest; 1992 Mar; 89(3):1021-31. PubMed ID: 1347295 [TBL] [Abstract][Full Text] [Related]
2. Tissue-specific galactosyltransferase abnormalities in an experimental model of rheumatoid arthritis. Alavi A; Axford JS; Hay FC; Jones MG Ann Med Interne (Paris); 1998 Sep; 149(5):251-60. PubMed ID: 9791557 [TBL] [Abstract][Full Text] [Related]
3. Serum galactosyltransferase isoform changes in rheumatoid arthritis. Alavi A; Axford JS; Pool AJ J Rheumatol; 2004 Aug; 31(8):1513-20. PubMed ID: 15290729 [TBL] [Abstract][Full Text] [Related]
4. IgG, IgA, IgM antibodies to a viral citrullinated peptide in patients affected by rheumatoid arthritis, chronic arthritides and connective tissue disorders. Anzilotti C; Riente L; Pratesi F; Chimenti D; Delle Sedie A; Bombardieri S; Migliorini P Rheumatology (Oxford); 2007 Oct; 46(10):1579-82. PubMed ID: 17717033 [TBL] [Abstract][Full Text] [Related]
6. IgG antibodies to type II collagen reflect inflammatory activity in patients with rheumatoid arthritis. Kim WU; Yoo WH; Park W; Kang YM; Kim SI; Park JH; Lee SS; Joo YS; Min JK; Hong YS; Lee SH; Park SH; Cho CS; Kim HY J Rheumatol; 2000 Mar; 27(3):575-81. PubMed ID: 10743792 [TBL] [Abstract][Full Text] [Related]
7. Advanced glycation endproducts (AGE) on IgG, a target for circulating antibodies in North American Indians with rheumatoid arthritis (RA). Newkirk MM; LePage K; Niwa T; Rubin L Cell Mol Biol (Noisy-le-grand); 1998 Nov; 44(7):1129-38. PubMed ID: 9846895 [TBL] [Abstract][Full Text] [Related]
8. Serologic changes following B lymphocyte depletion therapy for rheumatoid arthritis. Cambridge G; Leandro MJ; Edwards JC; Ehrenstein MR; Salden M; Bodman-Smith M; Webster AD Arthritis Rheum; 2003 Aug; 48(8):2146-54. PubMed ID: 12905467 [TBL] [Abstract][Full Text] [Related]
9. Anti-Fc gamma receptor III autoantibody is associated with soluble receptor in rheumatoid arthritis serum and synovial fluid. Lamour A; Baron D; Soubrane C; Cartron J; Khayat D; Adler Y; Le Goff P; Youinou P J Autoimmun; 1995 Apr; 8(2):249-65. PubMed ID: 7612151 [TBL] [Abstract][Full Text] [Related]
10. The exploration of joint-specific immunoreactions on immunoglobulins G of anti-glucose-6-phosphate isomerase antibody-positive patients with rheumatoid arthritis. Matsumoto I; Muraki Y; Yasukochi T; Hua Z; Kori Y; Hayashi T; Goto D; Ito S; Tsutsumi A; Ikeda K; Sumichika H; Sumida T Int J Mol Med; 2005 Nov; 16(5):793-800. PubMed ID: 16211246 [TBL] [Abstract][Full Text] [Related]
11. Differential B lymphocyte galactosyltransferase activity in the MRL mouse model of rheumatoid arthritis. Axford JS; Alavi A; Bond A; Hay FC Autoimmunity; 1994; 17(2):157-63. PubMed ID: 8061165 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of beta 1,4-galactosyltransferase in rheumatoid arthritis and its role in the glycosylation network associated with this disease. Alavi A; Axford J Glycoconj J; 1995 Jun; 12(3):206-10. PubMed ID: 7496133 [TBL] [Abstract][Full Text] [Related]
13. IgA and IgM rheumatoid factors in serum, saliva and other secretions: relationship to immunoglobulin ratios in systemic sicca syndrome and rheumatoid arthritis. Elkon KB; Gharavi AE; Patel BM; Hughes GR; Frankel A Clin Exp Immunol; 1983 Apr; 52(1):75-84. PubMed ID: 6861373 [TBL] [Abstract][Full Text] [Related]
14. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis. Newkirk MM; Goldbach-Mansky R; Senior BW; Klippel J; Schumacher HR; El-Gabalawy HS Rheumatology (Oxford); 2005 Nov; 44(11):1433-41. PubMed ID: 16091399 [TBL] [Abstract][Full Text] [Related]
15. Immunoglobulin G glycosylation and clinical outcome in rheumatoid arthritis during pregnancy. Alavi A; Arden N; Spector TD; Axford JS J Rheumatol; 2000 Jun; 27(6):1379-85. PubMed ID: 10852257 [TBL] [Abstract][Full Text] [Related]
16. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis. Greiner A; Plischke H; Kellner H; Gruber R Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545 [TBL] [Abstract][Full Text] [Related]
17. In vitro effect of thymosin on T-lymphocyte rosette formation in rheumatic diseases. Moutsopoulos H; Fye KH; Sawada S; Becker MJ; Goldstein A; Talal N Clin Exp Immunol; 1976 Dec; 26(3):563-73. PubMed ID: 795579 [TBL] [Abstract][Full Text] [Related]
18. Mapping IgG epitopes bound by rheumatoid factors from immunized controls identifies disease-specific rheumatoid factors produced by patients with rheumatoid arthritis. Bonagura VR; Agostino N; Børretzen M; Thompson KM; Natvig JB; Morrison SL J Immunol; 1998 Mar; 160(5):2496-505. PubMed ID: 9498795 [TBL] [Abstract][Full Text] [Related]
19. Balance between survivin, a key member of the apoptosis inhibitor family, and its specific antibodies determines erosivity in rheumatoid arthritis. Bokarewa M; Lindblad S; Bokarew D; Tarkowski A Arthritis Res Ther; 2005; 7(2):R349-58. PubMed ID: 15743483 [TBL] [Abstract][Full Text] [Related]
20. Aberrant control of galactosyltransferase in peripheral B lymphocytes and Epstein-Barr virus transformed B lymphoblasts from patients with rheumatoid arthritis. Wilson IB; Platt FM; Isenberg DA; Rademacher TW J Rheumatol; 1993 Aug; 20(8):1282-7. PubMed ID: 8230006 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]